Sera Novo, one of our previous competition winners is really working hard on their new platform of medicine formulation. They recently acquired a €300.000 investment from UNIIQ. Sera Novo’s technology enables a new way of dissolving medicines and thereby enhances the chance of positive effect to the patient.
Medicines that did not have a positive effect to the patient in another dissolvent can now be really valuable. This opens up a wide range of medicines that could be further developed using their techniques.
Past Gulliver Winner Sera Novo acquires new funding
Sera Novo, one of our previous competition winners is really working hard on their new platform of medicine formulation. They recently acquired a €300.000 investment from UNIIQ. Sera Novo’s technology enables a new way of dissolving medicines and thereby enhances